Sage Journals: Discover world-class research

Free access

Research article

First published 2018-10

Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression

Marco Antonio Caldieraro, Samantha Walsh, Thilo Deckersbach [...]

Australian & New Zealand Journal of Psychiatry

Retricted access

Research article

First published 2011-11

Remission and Dropout Rate of Anti-VEGF Therapy for Age-Related Macular Degeneration

Akio Oishi, Michiko Mandai, Akihiro Nishida [...]

European Journal of Ophthalmology

Open access

Research article

First published 2024

Early intervention with Ustekinumab is associated with higher rates of clinical and endoscopic remission in patients with Crohn’s disease

Tong Tu, Mengqi Chen, Manying Li [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2018-3

Remission of chronic headache: Rates,potential predictors and the role of medication,follow-up results of the German Headache Consortium (GHC) Study

Verena Henning, Zaza Katsarava, Mark Obermann [...]

Cephalalgia

Retricted access

Research article

First published 2015-11

Refining Clinical Judgment of Treatment Response and Symptom Remission Identification in Childhood Anxiety Using a Signal Detection Analysis on the Pediatric Anxiety Rating Scale

Carly J. Johnco, Alison Salloum, Adam B. Lewin [...]

Journal of Child and Adolescent Psychopharmacology

Free access

Research article

First published 2016-8

Reduced heart rate variability in remitted bipolar disorder and recurrent depression

Darryl Bassett, Natasha Bear, David Nutt [...]

Australian & New Zealand Journal of Psychiatry

Retricted access

Research article

First published 2019-09

Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial

Fereidoun Azizi, Atieh Amouzegar, Maryam Tohidi [...]

Thyroid®

Open access

Research article

First published 2022

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Péter Bacsur, Mária Matuz, Tamás Resál [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2024-7

An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia

Xuan Zhou, Zhen-Fei Li, Xuan-Zhu Guo [...]

Technology and Health Care

Retricted access

Research article

First published 2021-07

Rate of Remission Is the Most Important Determinant for Treatment Decision-Making in Graves’ Disease

Omar M. El Kawkgi, Juan P. Brito

Clinical Thyroidology®

Search results